EMFAT
VNDA icon

Emerald Mutual Fund Advisers Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-251,730
Closed -$4.13M – 309
2019
Q4 		$4.13M Buy
+251,730
New +$3.81M 0.17% 146

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's VNDA Position: Q1 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of Vanda Pharmaceuticals (VNDA) in Q1 2020, closing a stake of 251,730 shares — an estimated $4.13M sold.

Emerald Mutual Fund Advisers Trust first reported a position in VNDA in Q4 2019 and held it in 1 quarter. The position peaked at $4.13M in Q4 2019. 159 funds tracked by Wall St. Rank hold VNDA as of Q1 2020.

  • Emerald Mutual Fund Advisers Trust reported no remaining Vanda Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 251,730 Vanda Pharmaceuticals shares in Q1 2020, an estimated $4.13M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Vanda Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Emerald Mutual Fund Advisers Trust's Vanda Pharmaceuticals position peaked at $4.13M in Q4 2019.
  • 159 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.